JAK1 抗体
JAK1 适用: 人, 小鼠, 大鼠 WB, IHC, ELISA, IF, ICC 宿主: 兔 Polyclonal unconjugated
JAK1 适用: 人, 小鼠, 大鼠 WB, ELISA, IF, IHC (p) 宿主: 兔 Polyclonal unconjugated
JAK1 抗体 by 适用
Find JAK1 抗体 for a variety of species such as anti-Human JAK1, anti-Mouse JAK1, anti-Rat JAK1. The species listed below are among those available. Click on a link to go to the corresponding products.
JAK1 抗体 by 抗体来源
Find JAK1 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
JAK1 抗体 by 克隆形成能力
Find available monoclonal or polyclonal JAK1 抗体. Click on a link to go to the corresponding products.
JAK1 抗体 by 克隆
Find JAK1 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.
Popular JAK1 抗体
- (4)
- (12)
- (4)
- (4)
- (2)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (3)
- (3)
- (1)
- (1)
- (1)
Latest Publications for our JAK1 抗体
: "Single-cell-level protein analysis revealing the roles of autoantigen-reactive B lymphocytes in autoimmune disease and the murine model." in: eLife, Vol. 10, (2021) (PubMed).: "Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions." in: Frontiers in immunology, Vol. 11, pp. 344, (2021) (PubMed).
: "In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3." in: Journal of cellular physiology, Vol. 234, Issue 4, pp. 3500-3514, (2019) (PubMed).
: "Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway." in: Oncology reports, Vol. 39, Issue 3, pp. 1081-1089, (2018) (PubMed).
: "A novel fluorinated triazole derivative suppresses macrophage activation and alleviates experimental colitis via a Twist1-dependent pathway." in: Biochemical pharmacology, Vol. 155, pp. 275-287, (2018) (PubMed).
: "Hydrogen sulfide attenuates myocardial fibrosis in diabetic rats through the JAK/STAT signaling pathway." in: International journal of molecular medicine, Vol. 41, Issue 4, pp. 1867-1876, (2018) (PubMed).
: "BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo." in: Molecular carcinogenesis, Vol. 56, Issue 3, pp. 1137-1149, (2017) (PubMed).
: "Roflumilast reverses polymicrobial sepsis-induced liver damage by inhibiting inflammation in mice." in: Laboratory investigation; a journal of technical methods and pathology, Vol. 97, Issue 9, pp. 1008-1019, (2017) (PubMed).
: "Enhancing NK cell-mediated cytotoxicity to cisplatin-resistant lung cancer cells via MEK/Erk signaling inhibition." in: Scientific reports, Vol. 7, Issue 1, pp. 7958, (2017) (PubMed).
: "Direct effect of dasatinib on signal transduction pathways associated with a rapid mobilization of cytotoxic lymphocytes." in: Cancer medicine, Vol. 5, Issue 11, pp. 3223-3234, (2016) (PubMed).
Aliases for JAK1 抗体
Janus kinase 1 (JAK1) 抗体Janus kinase 1 (Jak1) 抗体
Janus kinase 1 (jak1) 抗体
tyrosine-protein kinase JAK1 (LOC100286690) 抗体
AA960307 抗体
C130039L05Rik 抗体
jak1 抗体
JAK1A 抗体
JAK1B 抗体
JTK3 抗体
wu:fb93e10 抗体
